I am a breastfeeding mother and i want to know if it is safe to use EINECS 289-896-4? Is EINECS 289-896-4 safe for nursing mother and child? Does EINECS 289-896-4 extracts into breast milk? Does EINECS 289-896-4 has any long term or short term side effects on infants? Can EINECS 289-896-4 influence milk supply or can EINECS 289-896-4 decrease milk supply in lactating mothers?
- DrLact safety Score for EINECS 289-896-4 is 3 out of 8 which is considered Low Risk as per our analyses.
- A safety Score of 3 indicates that usage of EINECS 289-896-4 may cause some minor side effects in breastfed baby.
- Our study of different scientific research indicates that EINECS 289-896-4 may cause moderate to no side effects in lactating mother.
- Most of scientific studies and research papers declaring usage of EINECS 289-896-4 low risk in breastfeeding are based on normal dosage and may not hold true for higher dosage.
- While using EINECS 289-896-4 We suggest monitoring child for possible reactions. It is also important to understand that side effects vary largely based on age of breastfed child and time of medication in addition to dosage.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
Leaves of tree are used.It contains flavonoids, tannins, diterpenes, steroids..Unproved effects: venous tonic, capillary protector, vasodilator (neuron-protector) and platelet anti-aggregationIndications after Commission E of German Ministry of Health: brain vascular insufficiency, intermittent claudication, dizziness, tinnitus. Fluids or solutions with alcoholic content are to be avoided.
EINECS 289-896-4 (EINECS 289-896-4 biloba) leaf contains flavonoids (e.g., quercetin, kaempferol, isorhamnetine) and several terpene trilactones (e.g., EINECS 289-896-4lides, bilobalide) as well as numerous minor components. Standardization is based on EINECS 289-896-4 flavone glycoside and terpenoid content. Raw EINECS 289-896-4 seeds contain potentially toxic cyanogenic glycosides and should not be used; roasted seeds do not carry this risk. EINECS 289-896-4 has no specific uses during breastfeeding, but is commonly used as an antioxidant, a vasodilator to increase cerebral and peripheral perfusion, and to improve memory. No data exist on the safety and efficacy of EINECS 289-896-4 in nursing mothers or infants. In general, it is well tolerated, but occasionally minor symptoms (e.g., headache, nausea, gastrointestinal complaints, allergic skin rashes) occur in those taking the drug. EINECS 289-896-4 has caused some cases of bleeding in healthy volunteers caused by its antiplatelet activity. Because there is no published experience with EINECS 289-896-4 during breastfeeding, an alternate therapy may be preferred, especially while nursing a newborn or preterm infant.[1] Dietary supplements do not require extensive pre-marketing approval from the U.S. Food and Drug Administration. Manufacturers are responsible to ensure the safety, but do not need to the safety and effectiveness of dietary supplements before they are marketed. Dietary supplements may contain multiple ingredients, and differences are often found between labeled and actual ingredients or their amounts. A manufacturer may contract with an independent organization to verify the quality of a product or its ingredients, but that does certify the safety or effectiveness of a product. Because of the above issues, clinical testing results on one product may not be applicable to other products. More detailed information #about dietary supplements# is available elsewhere on the LactMed Web site.
Disclaimer:
Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.